Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma
A completed clinical trial update describing the intake conditions for sunitinib in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial results comparing pazopanib to sunitinib in Asian patients with locally advanced or metastatic renal cell carcinoma were repor…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AGS-003, an autologous dendritic cell–based immunotherapy, for biologic activity and safety in patients with ne…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib [Phase 3]
Phase 3 trial comparing temsirolimus to sorafenib as second-line therapy in advanced renal cell carcinoma after failure of first-line suniti…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Phase 2]
This update summarizes results from a Phase 2 trial evaluating the combination of bevacizumab (Avastin) and everolimus (RAD001) for advanced…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
This Phase 2 clinical trial evaluated the combination of sorafenib and interferon alfa in patients with metastatic or unresectable renal cel…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib for locally advanced or metastatic papillary renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of AGS-16M18 in subjects with advanced renal cell carcinoma; the trial was terminat…
-
CLINICAL_TRIALS withdrawal · 2013-02-27Clinical Trial Update: RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma [NA]
This clinical trial investigating radiofrequency ablation of metastatic lesions in patients receiving antiangiogenic therapy for stage IV re…
-
CLINICAL_TRIALS research · 2013-02-25Clinical Trial Update: Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma [Phase 3]
Clinical trial update of a Phase 3 study comparing sequential sunitinib and sorafenib in metastatic renal cell carcinoma; status is unknown.
-
CLINICAL_TRIALS withdrawal · 2013-02-20Clinical Trial Update: S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
SWOG trial S0351 evaluating CNTO 328 for unresectable or metastatic kidney cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: RNA-Loaded Dendritic Cell Cancer Vaccine [Phase 1, Phase 2]
Clinical trial update indicates completion of a Phase 1/Phase 2 study evaluating an RNA-loaded dendritic cell cancer vaccine for renal cell …
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of temsirolimus and bevacizumab for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain [Phase 2]
Phase 2 clinical trial update evaluating sorafenib for patients with metastatic renal cell carcinoma that has spread to the brain. The study…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bryostatin-1 in metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Phase 2 Study in Patients With MiT Tumors [Phase 2]
Phase 2 study of tivantinib in MiT family tumors including renal cell carcinoma, alveolar soft part sarcoma, and clear cell sarcoma has been…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer [Phase 2]
Phase 2 trial update of interleukin-2 and bryostatin-1 in patients with advanced renal cell carcinoma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment [Phase 2]
Phase 2 trial of Semaxanib (SU5416) for metastatic renal cell carcinoma that failed prior therapy was terminated. This document serves as a …
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer [Phase 2]
A phase 2 clinical trial evaluating lenalidomide in patients with advanced or unresectable kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial of carboxyamidotriazole for metastatic renal cell carcinoma (recurrent or stage IV) conducted by the National Cancer Institu…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib [Phase 3]
Phase 3 trial comparing everolimus plus best supportive care versus placebo plus best supportive care in metastatic renal cell carcinoma tha…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib [Phase 2]
A Phase 2 study of ABT-869 (linifanib) in advanced renal cell carcinoma following prior sunitinib treatment has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma [Phase 2]
Phase 2 trial of doxorubicin and gemcitabine in locally recurrent or unresectable metastatic renal cell carcinoma (including sarcomatoid fea…
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in patients undergoing surgery for metastatic kidney cancer was terminated; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma [Phase 4]
Phase 4 trial assessing safety and efficacy of sunitinib malate as first-line therapy in Chinese patients with metastatic renal cell carcino…